U.S. biopharmaceutical firm Gilead Sciences Inc. said Monday it applied with the Japanese health ministry for approval to use its anti-viral drug remdesivir to treat new coronavirus patients, paving the way for its clearance as early as this week.Health minister Katsunobu Kato said Saturday he wants to give the green light "in about a week" after an application is made on remdesivir. The U.S. Food and Drug Administration said Friday it has authorized the emergency use of the drug for those hospitalized with severe illness caused by the virus.If approved, remdesivir would be the first therap…READ FULL ARTICLE
